Sort
39,280 grants matching “leukemia”
Role of LAM-specific TREM1 in leukemogenesis
$517,618Wei Du · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
$517,563Warren S Pear · University Of Pennsylvania · T32 · FY2018 · CA
CRISPR Tiling
$517,525Chun-Wei David Chen · St. Jude Children'S Research Hospital · P01 · FY2025 · CA
Therapeutic targeting of IRAK4 in MDS
$517,464Amit Verma · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Computational Tools for Next Generation Volumetric Cone Beam Computed Tomography
$517,384Lei Xing · Stanford University · R01 · FY2016 · EB
MOLECULAR CORRELATES OF HOXB4 FUNCTION
$517,314Bernard G Forget · Yale University · P01 · FY2008 · HL
Analysis of Nematode Sex Determination
$517,286Barbara J Meyer · University Of California Berkeley · R01 · FY2013 · GM
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$517,286Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2022 · DK
The role of cytotoxic T cells in rheumatoid arthritis pathogenesis
$517,284Felipe Andrade · Johns Hopkins University · R01 · FY2025 · AR
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$517,284Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2023 · DK
Metabolic approaches to treat severe viral and inflammatory diseases
$517,128Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2016 · AI
Metabolic approaches to treat severe viral and inflammatory diseases
$517,128Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2015 · AI
Metabolic approaches to treat severe viral and inflammatory diseases
$517,128Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2017 · AI
The Role and Function of a Novel Signature Gene in BCR::ABL1 (Ph) B-cell Acute Lymphoblastic Leukemia
$517,090Zhaohui Gu · Beckman Research Institute/City Of Hope · R37 · FY2025 · CA
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$517,066Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2025 · DK
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$516,975Marco Ruella · University Of Pennsylvania · R37 · FY2023 · CA
Carrier Mediated Antifolate Transport and Resistance
$516,963Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2006 · CA
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche
$516,884Anupriya Agarwal · Oregon Health & Science University · R01 · FY2023 · HL
Center for Advanced Multi-Omic Characterization of Cancer
$516,800Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2023 · CA
Mitotic roles of Nuclear Pore Complex (NPC) proteins
$516,725Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
$516,712Arti Hurria · Beckman Research Institute/City Of Hope · R01 · FY2014 · AG
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition
$516,669Jerry D Glickson · University Of Pennsylvania · R01 · FY2020 · CA
Novel Mcl-1 inhibitors for overcoming therapeutic resistance in colorectal cancer
$516,652Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Novel Mcl-1 inhibitors for overcoming therapeutic resistance in colorectal cancer
$516,593Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Advancing allogeneic CAR-iNKT for the treatment of solid tumors through comparative oncology
$516,527Nicola J Mason · University Of Pennsylvania · U01 · FY2022 · CA